Biosimilars are the next generation of drugs for liver and GI diseases
The latest issue of the Alimentary Pharmacology & Therapeutics reports that biosimilars are the next generation of drugs for liver and gastrointestinal diseases.
fiogf49gjkf04
A biosimilar is a copy version of an approved original biological medicine whose data protection